Yabo Zhou

16PUBLICATIONS
38CO-AUTHORS
Molecular targetsHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 30, 2026
Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP.

Yabo Zhou, Dianheng Wang, Shujing Wang

|Oct 15, 2025
Heterozygous human JAK2V617F activates AhR to drive essential thrombocythemia and promote thrombosis.

Li Zhou, Dongxiao Wu, Yabo Zhou

|Sep 11, 2024
Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells.

Huafeng Zhang, Jincheng Liu, Wu Yuan

|Mar 04, 2024
Sustained AhR activity programs memory fate of early effector CD8+ T cells.

Huafeng Zhang, Zhuoshun Yang, Wu Yuan

Pageof 3